首页> 外文期刊>Diagnostic cytopathology >Cytologic-histologic correlation of nongynecologic cytopathology cases: Separation of determinate from indeterminate cytologic diagnoses for analysis and monitoring of laboratory performance.
【24h】

Cytologic-histologic correlation of nongynecologic cytopathology cases: Separation of determinate from indeterminate cytologic diagnoses for analysis and monitoring of laboratory performance.

机译:非妇科细胞病理学病例的细胞学与组织学相关性:将不确定的细胞学诊断与确定的细胞学诊断分开,以分析和监测实验室性能。

获取原文
获取原文并翻译 | 示例
       

摘要

Much of the literature on the quality-assurance aspect of cytologic-histologic correlation (CHC) has focused on gynecologic cytology. For nongynecologic cytopathology, the process is complicated by the use of determinate (positive for malignant cells, negative for malignant cells) and indeterminate (atypical, suspicious, or follicular lesion) diagnostic categories. Here, we illustrate our routine methodology for analyzing CHC data on nongynecologic cytopathology cases by separating determinate from indeterminate cases. A focused list of determinate and indeterminate cytopathology cases with surgical pathology correlation is generated each week. The determinate cases are ascertained as true positive (TP), true negative (TN), false positive (FP), or false negative (TN). The discrepant cases (FP and FN) are investigated to determine the cause (sampling, interpretation, or screening). For indeterminate cases, the surgical pathology outcome (benign, malignant) and suitability of the cytopathology category utilized are reviewed. For the focused period of 4 mo, sensitivity was 70% and specificity was 100%. The most common reason for false-negative diagnoses was a sampling problem in the cytologic specimen; there were no false-positive diagnoses. Malignant outcomes for follicular lesion, atypical, and suspicious diagnoses were 29%, 40%, and 76%, respectively. Data derived from regularly performed CHC are useful in reviewing the diagnostic performance of the laboratory. Diagn. Cytopathol. 2003;28:28-34.
机译:细胞学-组织学相关性(CHC)的质量保证方面的许多文献都集中在妇科细胞学上。对于非妇科细胞病理学,使用确定的(对于恶性细胞为阳性,对于恶性细胞为阴性)和不确定的(非典型,可疑或滤泡性病变)诊断类别会使过程变得复杂。在这里,我们举例说明了通过将不确定病例与不确定病例分开来分析非妇科细胞病理学病例的CHC数据的常规方法。每周都会生成与手术病理相关的确定性和不确定性细胞病理学病例的重点清单。确定的情况确定为真阳性(TP),真阴性(TN),假阳性(FP)或假阴性(TN)。调查差异病例(FP和FN)以确定原因(抽样,解释或筛查)。对于不确定的病例,将回顾其手术病理结果(良性,恶性)和所用细胞病理学类别的适用性。对于4 mo的聚焦期,灵敏度为70%,特异性为100%。假阴性诊断的最常见原因是细胞学样本中存在采样问题。没有假阳性诊断。滤泡性病变,非典型和可疑诊断的恶性结果分别为29%,40%和76%。定期进行的CHC得出的数据可用于检查实验室的诊断性能。诊断细胞病。 2003; 28:28-34。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号